{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ATC|BLOOD AND BLOOD FORMING ORGANS|OTHER HEMATOLOGICAL AGENTS" in comments (approximate match)
Status:
First approved in 1955
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00627809: Phase 4 Interventional Completed Acute Coronary Syndromes
(2007)
Source URL:
Class:
PROTEIN
Status:
Other
Class:
CONCEPT